Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
SEER
#3963
Seer, Inc. Class A Common Stock
1.9
4
USD
+1.04%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+1.04%
Changement Mensuel
+7.18%
Evolution sur 6 mois
-13.00%
Changement Annuel
-7.18%
Clôture Précédente
1.9
2
Open
1.9
4
Bid
Ask
Low
1.9
4
High
1.9
4
Volume
4
Marchés
Actions des Marchés US
Soins de Santé
SEER
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
58.05 M
59.7 M
60.73 M
55.74 M
56.22 M
—
Valuation ratios
Enterprise value
1.18 B
319.7 M
93.16 M
97.34 M
55.97 M
261.73 M
Price to earnings ratio
-19.5
-3.93
-1.44
-1.66
-1.43
-5.76
Price to sales ratio
209.81
23.57
7.43
10.16
6.34
28.97
Price to cash flow ratio
-29.95
-6.01
-2.1
-3.12
-2.37
-9.95
Price to book ratio
2.76
0.82
0.31
0.44
0.41
0.69
Enterprise value to EBITDA ratio
-18.18
-3.54
-0.9
-1.15
-0.87
-3.64
Profitability ratios
Return on assets %
-0.13
-0.19
-0.2
-0.24
-0.25
-0.23
Return on equity %
-0.14
-0.21
-0.22
-0.26
-0.28
-0.26
Return on invested capital %
-214.16
-407.85
-495.63
-347.92
-279.59
-301.42
Gross margin %
51.56
45.78
51.05
49.79
51.06
204.29
Operating margin %
-1 080.14
-627.61
-620.99
-706.43
-470.45
-1 883.08
EBITDA margin %
-984.1
-582.37
-623.21
-597.54
-389.96
-1 561.41
Net margin %
-1 075.55
-600.05
-517.84
-611.14
-443.96
-1 777.06
Liquidity ratios
Quick ratio
30.36
34.2
24.66
16.04
12.35
63.38
Current ratio
30.67
34.57
25
16.53
12.84
65.59
Inventory turnover
—
0.12
0.19
0.03
0.02
0.02
Asset turnover
0.01
0.03
0.04
0.04
0.05
0.05
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.76
-0.97
-0.93
-0.74
-0.77
-0.76
EBIT per share
-1.17
-1.56
-1.62
-1.61
-1.36
-1.34
EBITDA per share
-1.07
-1.45
-1.63
-1.36
-1.13
-1.11
Total debt per share
—
—
—
—
—
—
Cash per share
8.1
6.83
5.84
4.8
4.19
17.81
Net current asset value per share
6.76
6.97
5.18
4.06
3.51
15.35
Tangible book value per share
8.26
7.16
6.22
5.25
4.51
19.35
Working capital per share
6.54
6.77
4.97
3.82
3.24
14.39
Book value per share
8.26
7.16
6.22
5.25
4.51
19.35
Seer Inc - Class A
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
Nouvelles
Seer reçoit une offre de rachat à 2,25$ par action d’un groupe d’investisseurs
Le PTAB invalide des revendications clés du brevet de Brigham and Women’s
Seer conserve ses revendications de brevet lors de l’examen USPTO
Seer modifie son plan de préservation fiscale et accepte 250.000$ dans un litige
Seer, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:SEER) 2026-02-27
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer T4 2025 : base installée en hausse de 67%, revenus décevants
Seer Q4 2025 slides: installed base surges 67%, revenue misses mark
Le BPA de Seer a dépassé les attentes de 0,02$, le CA en dessous des prévisions
Seer earnings beat by $0.02, revenue fell short of estimates
Seer présentera sa technologie protéomique lors de la conférence US HUPO
Seer to showcase proteomics technology at US HUPO conference